AngioDynamicsANGO
Market Cap: $304M
About: AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
Employees: 748
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
21% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 19
3% more funds holding
Funds holding: 133 [Q1] → 137 (+4) [Q2]
9% less capital invested
Capital invested by funds: $215M [Q1] → $196M (-$19.4M) [Q2]
11.04% less ownership
Funds ownership: 91.79% [Q1] → 80.75% (-11.04%) [Q2]
25% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 57
100% less funds holding in top 10
Funds holding in top 10: 1 [Q1] → 0 (-1) [Q2]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
HC Wainwright & Co. Yi Chen 41% 1-year accuracy 58 / 140 met price target | 86%upside $14 | Buy Reiterated | 20 Sept 2024 |
Canaccord Genuity William Plovanic 56% 1-year accuracy 15 / 27 met price target | 72%upside $13 | Buy Maintained | 17 Jul 2024 |
HC Wainwright & Co. Yi Chen 41% 1-year accuracy 58 / 140 met price target | 86%upside $14 | Buy Reiterated | 17 Jul 2024 |
Financial journalist opinion
Based on 7 articles about ANGO published over the past 30 days